WebJan 1, 2024 · Purpose: Individualized selection of patients with early-stage hormone receptor-positive (HR +) breast cancer for extended endocrine therapy (EET) is required to balance modest gains in outcome with toxicities of prolonged use.This study examined the Breast Cancer Index [BCI; HOXB13/IL17BR ratio (H/I)] as a predictive biomarker of … WebMay 10, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #breastcancer--Medicare Insurance Coverage for Breast Cancer Index™ Test Expanded to Include Node-Positive Breast Cancer 2024-05-10T20:02:00.000Z 0
Breast Cancer Index Test
WebBreast Cancer Index. 1,592 likes · 443 talking about this. THE ONLY commercially available genomic test validated to predict whether a woman with early-stage, HR+ breast cancer is likely to benefit... WebPlease contact Biotheranostics, Inc. at 877-886-6739. Turnaround Time 10 days Level of Service Global New York Approved Yes References Zhang Y, et al. J Clin Oncol. 2016; 34 (suppl abstr 541). Sanft T, et al. Breast Cancer Res Treat. 2015;154 (3):533-41. Sgroi DC, et al. Lancet Oncol. 2013;14:1067 – 76. cooling down in malay
Breast Cancer Index
WebJan 4, 2024 · Breast Cancer Index (or BCI) is a new test to help determine if you are likely to benefit from an additional five years of anti-estrogen medication. BCI can also provide … WebNot Another Minute Not Knowing. Breast cancer is complicated enough. Your doctor will receive your Breast Cancer Index ® results in one clear and easy-to-understand report. … WebBreast Cancer Index for Breast Cancer Prognosis MOL.TS.248.A v2.0.2024 Introduction Breast Cancer Index for breast cancer prognosis is addressed by this guideline. ... Rendering laboratory is a qualified provider of service per the Health Plan policy. Other Considerations Testing Multiple Samples: family resort beach vacations 5-star